Category Archives: Business of Biotech

Biotech Companies Find Solutions through Synthetic Biology

scientist, lab

Several small companies presented their business models and milestones in the New and Innovative Technological Advances breakout session during the opening day of BIO’s World Congress. Each of the companies started out seeking an alternative to petroleum as a raw material for plastics and other polymers used in everyday household products. Additionally, these companies were united in finding unique solutions to scientific challenges through synthetic biology approaches. Eric Althoff, CBO of ten-year-old Arzeda, described his Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

72263479

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

BIO Innovation Zone Company Snapshots: Iron Horse Diagnostics and Nimbic Systems

BIO Innovation Zone

This week in Philadelphia at the BIO International Convention, BIO is partnering with the National Institutes of Health (NIH) and the National Science Foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone, which opens tomorrow, will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Innovation Zone Company Snapshots: Aciont Inc. and TF Health Co.

BIO Innovation Zone

This week in Philadelphia at the BIO International Convention, BIO is partnering with the National Institutes of Health (NIH) and the National Science Foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone, which opens tomorrow, will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Innovation Zone Company Snapshots: Delsys, Immunetics, and Advanced Plasma Products

BIO Innovation Zone

Next week in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science Foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process prior to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,